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Background {#sec001}
==========

Systematic reviews constitute the backbone of evidence-based medicine (EBM) in all fields of medicine. Among the different study types that rely upon evidence-based medicine, the Cochrane Database of Systematic Reviews (CDSR) plays a key role in this important field of medicine \[[@pone.0226305.ref001]\]. Besides the benefits of CDSRs, there has to be some critical issues to be raised. To be named are the lack of comparability, the risks of bias, indirectness, imprecision, and inconsistency \[[@pone.0226305.ref002]\]. While the CDSR has nearly published 10,000 systematic reviews so far, the underlying architecture has not been analyzed so far using advanced scientometric tools. In order to address this issue and to depict a first sketch of the global landscape of systematic reviews, we used the NewQIS platform, which was established in 2007/8 \[[@pone.0226305.ref003], [@pone.0226305.ref004]\]. So far, about 50 different biomedical entities were analyzed on the basis of NewQIS ranging from infectious diseases such as Ebola to cancer or even health care policy issues \[[@pone.0226305.ref005]--[@pone.0226305.ref007]\]. To generate maps of systematic reviewing, the Web of Science (WoS) Core Collection database was used since it also allows citation analysis and density equalizing projections, established by Gastner and Newman \[[@pone.0226305.ref008]\]. All CDSR articles were analyzed and reviewed with a focus on the question arises who dominates systematic reviewing processes from a global viewpoint. Since US institutions are known to play a prominent role in almost every area of medicine \[[@pone.0226305.ref009]\], it was hypothesized that they also dominate systematic reviewing in the CDSR.

Methods {#sec002}
=======

NewQIS protocol {#sec003}
---------------

We used the previously established NewQIS platform to analyze all CDSR publications present in the Web of Science (WoS) Core Collection database. The WoS was chosen because of the ability to analyze citations.

Search protocol {#sec004}
---------------

We identified all relevant articles by searching the WoS for the following string: PUBLICATION NAME: Cochrane Database of Systematic Reviews, Refined by DOCUMENT TYPES: review or article, Timespan: all years.

Density-equalizing mapping {#sec005}
--------------------------

Density-equalizing mapping projections (DEMPs) were used: In brief, DEMPs algorithms based on Gastner and Newman's algorithm \[[@pone.0226305.ref008]\] were used to re-size country territories with regard to the following variables: 1) number of published items of each country, 2) the number of institutions in each country, 3) the number of citations for each country, 4) the country-specific modified Hirsch index. The original Hirsch (H)-index for authors was defined by Jorge Hirsch, representing a quantifying index (h): h is the maximum number from the total number of articles written by a given author where each one of these h articles have been at least h times cited. Presently, a modified h index was used to quantify citations of countries as previously performed in the NewQIS studies.

Network analysis {#sec006}
----------------

A matrix with all participant countries was computed and transformed into a vector graphic. The vector thickness illustrates the numbers of co-operations between two countries. A threshold of at least two collaborations was set.

Contextual factors {#sec007}
------------------

Socio-economic data was obtained from the World Factbook \[[@pone.0226305.ref010]\]. The values of the Gross Domestic Product (GDP) per publishing country were related to publication activities. The number of researchers in full time equivalent (FTE) per mill. inhabitants was extracted from the UNESCO database \[[@pone.0226305.ref011]\]. Consequently, these number were also set in relation to the number of CDSRs.

Results {#sec008}
=======

General activity {#sec009}
----------------

A total of n = 9,765 CDSR articles were identified using the above described search methodology. When these publications were ranked for the highest country activities, the UK was ranked no. 1 with a total of n = 4,261 articles. It was followed by Australia with a total of n = 1.596. At third position, the USA was listed with n = 1,309 articles, followed by Canada (n = 1,094). Active countries were also the Netherlands (n = 699), China (n = 576), Italy (n = 466), Germany (n = 423), New Zealand (n = 376), Brazil (n = 292), Switzerland (n = 260), Denmark (n = 223), India (n = 208), and Ireland (n = 201). When all countries are analyzed using density equalizing mapping, a global landscape appears, which is largely distorted towards Europe with the UK, Northern America with Canada and the USA, and Australia ([Fig 1A](#pone.0226305.g001){ref-type="fig"}). While Africa nearly disappears, Eastern Asia is visible due to Chinese contributions (n = 576).

![World map of Cochrane database of systematic review activity.\
A) Density equalizing map projection of the number of articles per country. B) Density equalizing map projection of the number of citations.](pone.0226305.g001){#pone.0226305.g001}

Quality parameters {#sec010}
------------------

To approach (semi-)qualitative aspects of CDSR research, citation analysis was performed using a variety of benchmarks. In the absolute citation ranking, the UK was ranked no.1 (c = 63,974 citations), followed by Australia (c = 25,894), Canada (c = 21,213), the US (c = 18,971), the Netherlands (c = 9,559), New Zealand (c = 6,884), Italy (n = 6,602), Germany (c = 6,587), Switzerland (c = 4,261), and Norway (c = 3,566), China (c = 3,555), and Denmark (c = 3,547). Density equalizing mapping leads to a distortion of the world map ([Fig 1B](#pone.0226305.g001){ref-type="fig"}) that largely follows the total publication activity mapping. The citation rate analysis shows a different ranking: The highest number of citations per review (cr) is found for Norway (cr = 32.41), followed by Canada (cr = 19.39), and New Zealand (cr = 18.3), underlying a threshold of at least 30 CDSRs. The UK has a citation rate of about cr = 15 and the USA of cr = 14.5 ([Fig 2](#pone.0226305.g002){ref-type="fig"}). The country-specific h-index (hI) analysis lists the UK at hI = 89, followed by Australia (hI = 69), Canada (hI = 66) and the US (hI = 60) ([Fig 2](#pone.0226305.g002){ref-type="fig"}).

![World map of Cochrane database of systematic review activity.\
A) Density equalizing map projection of the citation rates. B) Density equalizing map projection of the country-specific h-indices.](pone.0226305.g002){#pone.0226305.g002}

International networking {#sec011}
------------------------

Networking analysis of all articles shows that there are strong bonds between the UK (1,937 out of all 4,261 UK reviews are performed as international collaborations) and Australia, the US and Canada. Interestingly, the US has a much higher percentage of collaborative articles (903/1,309 = 69%) than the UK (45.5%) or Australia (54.6%). There are also countries such as Sweden (94.3%), which publish nearly all reviews within an international collaboration ([Fig 3](#pone.0226305.g003){ref-type="fig"}).

![International network--number of multinational cooperation articles.](pone.0226305.g003){#pone.0226305.g003}

Contextual factors {#sec012}
------------------

When the economic strength of the highly industrialized countries is related to the systematic reviewing activities of these countries. The following data are obtained ([Table 1](#pone.0226305.t001){ref-type="table"}): New Zealand publishes a calculated 2.151 reviews per 1000 billion US\$ Gross Domestic Product (GDP), the UK 1,528 reviews per 1000 billion US\$ GDP and Australia 1,342. By comparison, the USA publishes about 71 systematic reviews per 1000 billion US\$ GDP, Germany 106 and China 27 systematic reviews per 1000 billion US\$ GDP, respectively. Secondly, the number of reviews can also be related to the number of researchers (FTE) per mill. inhabitants (researchers per capita): Here, the UK leads with 0.97 reviews per researchers per capita, followed by India with 0.96 reviews per researchers per capita, and Colombia with 0.83 reviews per researchers per capita. China has 0.47 reviews per researchers per capita ranking 10^th.^ The US is ranked 12^th^ with 0.31 reviews per researchers per capita.

10.1371/journal.pone.0226305.t001

###### Cochrane database of systematic reviews--socio-economic features.

GDP Gross Domestic Product; bn billion; USD United States Dollar; HI high-income country; UMI upper-middle-income country; LMI lower-middle-income country, FTE full time equivalents. Sources: GDP (bn USD) \[[@pone.0226305.ref010]\], Number of Researcher (FTE) per mill. inhabitants \[[@pone.0226305.ref011]\],--no data available.

![](pone.0226305.t001){#pone.0226305.t001g}

  Country          No. of articles   GDP (bn USD)   Articles/GDP (1000 bn USD)   Rank   Researchers (FTE) per mill. inhabitants   Articles/ Researchers (FTE) per mill. inhabitants   Rank
  ---------------- ----------------- -------------- ---------------------------- ------ ----------------------------------------- --------------------------------------------------- ------
  New Zealand      376               174.8          2151.03                      HI1    4052.42                                   0.0928                                              HI8
  United Kingdom   4261              2788           1528.34                      HI2    4376.96                                   0.9735                                              HI1
  Australia        1596              1189           1342.30                      HI3    --                                        --                                                  --
  Bahrain          75                66.37          1130.03                      HI4    368.90                                    0.2033                                              HI5
  Denmark          223               264.8          842.15                       HI5    7896.85                                   0.0282                                              HI14
  Netherlands      699               865.9          807.25                       HI6    5007.06                                   0.1396                                              HI7
  Canada           1094              1674           653.52                       HI7    4274.70                                   0.2559                                              HI4
  Ireland          201               324.3          619.80                       HI8    4107.60                                   0.0489                                              HI13
  Switzerland      260               494.3          526.00                       HI9    5257.36                                   0.0495                                              HI12
  Croatia          31                94.24          328.95                       HI10   1865.44                                   0.0166                                              HI18
  Finland          78                239.2          326.09                       HI11   6707.49                                   0.0116                                              HI22
  South Africa     239               736.3          324.60                       HI12   493.72                                    0.4841                                              HI2
  Norway           110               364.7          301.62                       HI13   6477.76                                   0.0170                                              HI17
  Israel           80                297            269.36                       HI14   8250.47                                   0.0097                                              HI24
  Sweden           106               498.1          212.81                       HI15   7592.50                                   0.0140                                              HI21
  Italy            466               2221           209.82                       HI16   2294.55                                   0.2031                                              HI6
  Belgium          95                508.6          186.79                       HI17   4941.98                                   0.0192                                              HI16
  Portugal         48                297.1          161.56                       HI18   4290.82                                   0.0112                                              HI23
  Greece           46                290.5          158.35                       HI19   3152.84                                   0.0146                                              HI20
  Thailand         147               1161           126.61                       UMI1   1210.35                                   0.1215                                              UMI5
  Austria          50                415.9          120.22                       HI20   5157.52                                   0.0097                                              HI25
  Singapore        58                486.9          119.12                       HI21   6729.68                                   0.0086                                              HI26
  Spain            191               1690           113.02                       HI22   2873.41                                   0.0665                                              HI11
  Germany          423               3979           106.31                       HI23   5036.18                                   0.0840                                              HI9
  Colombia         73                690.4          105.74                       UMI2   88.48                                     0.8250                                              UMI1
  Nigeria          114               1089           104.68                       LMI1   --                                        --                                                  --
  Malaysia         87                863.8          100.72                       UMI3   2357.92                                   0.0369                                              UMI8
  Venezuela        46                468.6          98.16                        UMI4   283.93                                    0.1620                                              UMI4
  Chile            41                436.1          94.02                        HI24   502.10                                    0.0817                                              HI10
  Brazil           292               3135           93.14                        UMI5   881.38                                    0.3313                                              UMI3
  United States    1309              18560          70.53                        HI25   4256.29                                   0.3075                                              HI3
  Argentina        60                879.4          68.23                        UMI6   1232.60                                   0.0487                                              UMI7
  Egypt            62                1105           56.11                        LMI2   669.39                                    0.0926                                              LMI4
  Philippines      32                801.9          39.91                        LMI3   187.66                                    0.1705                                              LMI2
  Pakistan         39                988.2          39.47                        LMI4   354.13                                    0.1101                                              LMI3
  France           88                2737           32.15                        HI26   4441.07                                   0.0198                                              HI15
  Saudi Arabia     47                1731           27.15                        HI27   --                                        --                                                  --
  China            576               21270          27.08                        UMI7   1234.78                                   0.4665                                              UMI2
  Iran             35                1459           23.99                        UMI8   671.02                                    0.0522                                              UMI6
  India            208               8721           23.85                        LMI5   216.18                                    0.9622                                              LMI1
  Japan            81                4932           16.42                        HI28   5304.90                                   0.0153                                              HI19

In consideration of the socio-economic parameters GDP and total population of the publishing countries a clear economic related distribution appears ([Fig 4](#pone.0226305.g004){ref-type="fig"}).

![Countries' distribution pattern regarding the number of reviews per inhabitants in mill. and the number of reviews per GDP (gross domestic product) per 1000 bn US-dollars.](pone.0226305.g004){#pone.0226305.g004}

Discussion {#sec013}
==========

The area of evidence-based medicine has increasing importance in all areas of medicine. We analyzed the Cochrane database systematic reviews using the NewQIS platform and density equalizing approaches and found striking contrasts to the usual global research patterns: A large study analyzed a number of 5,527,558 publications and showed the usually clear dominance in biomedicine of the USA. The USA was by far the most productive country with nearly 1.9 million reviews. Japan ranked second with 573,473 reviews. The third most active country was Germany (n = 444,775), followed by the UK (n = 415,499). When oncology is focused, a similar lead position for the US is present in numerous cancers including ovarian cancer \[[@pone.0226305.ref006]\], breast cancer \[[@pone.0226305.ref012]\], pancreatic cancer \[[@pone.0226305.ref013]\] or laryngeal cancer \[[@pone.0226305.ref014]\], as previously demonstrated. In contrast, our findings show the UK being by far the leading country within the area of systematic reviews. Thus, our primary hypothesis needs to be rejected. Out of the 9,765 CDSRs included in our analysis, 4,261 originated from the UK and just 1,309 articles from the USA. A further interesting finding is that China appears to be strong with 576 reviews, in contrast with Japan with just 81 reviews. Even Malaysia (n = 87) appeared to be more active in this area of the world. Noteworthy, Japanese research activity is currently regarded to be decreasing in contrast to China \[[@pone.0226305.ref015]\]. As reported by N. Philips \[[@pone.0226305.ref016]\], Japan\'s Council for Science, Technology and Innovation conceded in on its Fifth Science and Technology Basic Plan (2015) that its world standing in science and technology was falling.

The total number of systematic reviews might represent a good marker for overall activities in the field of clinical medicine, in which evidence based diagnosis and treatment are of great importance \[[@pone.0226305.ref017]\]--but how meaningful are they? This can be approximated by citation analysis. Total numbers of citations largely follow the total numbers of publications. More detailed information can be obtained by assessing the citation rates and country-specific h-indices. Here, the highest citation rate is present for Norway, followed by Canada and New Zealand. A similar pattern with Scandinavian countries in the leading position has also been discovered in other studies \[[@pone.0226305.ref018]\]. To the same extend, Scandinavian countries such as Sweden seem to have a very high degree of collaborative research--we found that 94.3% of all Swedish Cochrane articles were published as international collaboration. It is noteworthy that the US also have a relatively high proportion of international collaborations (69%).

Since systematic reviews constitute the backbone of evidence-based medicine, highly industrialized countries should allocate reasonable resources to the advancement of science in this field. Our calculations show that the Commonwealth countries New Zealand (calculated 2.151 reviews per 1000 billion US\$ GDP), the UK (1.528 reviews per 1000 billion US\$ GDP). and Australia (1.342 reviews per 1000 billion US\$ GDP) are very active with the US just publishes about 71 systematic reviews per 1000 billion US\$ GDP. Again, Japan has a very poor rate with 16.42 systematic reviews per 1000 billion US\$ GDP. The UK also lead when the global Cochrane database systematic review activity is related to the countries´ number of researchers per capita. With India (n = 208) and Colombia (n = 73), two countries that have no high-income status are ranked next. The most collaborations of the Indian reviews were worked out with the UK. Colombia mostly worked together with Spain. Both connections are certainly caused by the historical connection and the common language.

What is the reason for this imbalance within highly industrialized countries such as the USA and highly industrialized Commonwealth countries such as the UK or Australia? One reason might be found in the history of the Cochrane database of systematic reviews. Cochrane is named in honor of Professor Archibald Cochrane, a Scottish physician who pioneered the field of evidence-based medicine. His visions were the founding principles that led to the opening of the first Cochrane Centre in Oxford, UK in 1992 and the founding of the Cochrane Collaboration in 1993 \[[@pone.0226305.ref019]\]. A second reason might be the geographical distribution of Cochrane Review Group editorial bases and the British origin of most of the editors. However, countries without review group editorial bases in countries such as China, Switzerland, Brazil, Ireland, or India are much more active than countries with bases in countries such as France or Portugal.

Conclusions {#sec014}
===========

The established global maps in this study offer intriguing insights into the world of Cochrane systematic reviews that form the basis of evidence-based medicine. They clearly show that the UK and Commonwealth countries take the lead position in this extremely important field of medicine. Patients, care providers and health systems all over the world benefit from this commitment. With regard to the unusual *non-leading* role of the US and the great potential of US institutions, clinicians and scientists from the US should foster their activities in this field. Future studies using novel approaches might also assess gender distribution of Cochrane authors \[[@pone.0226305.ref020], [@pone.0226305.ref021]\].
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